Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer

NCT00006033 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: gene therapy
BIOLOGICAL: interleukin-2 gene
DRUG: methotrexate

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]